Core Scientific
In Howard Marks's portfolio · Oaktree Capital Management
Ticker CORZ
Still in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2026Call options | Add 43% | 5,000,000 | 1.8% |
| Q2 2026 | Reduce 47% | 4,993,708 | 1.8% |
| Q1 2026Call options | Add 75% | 3,500,000 | 0.8% |
| Q1 2026 | Add 12% | 9,350,708 | 2.1% |
| Q4 2025 | Add 30% | 8,350,708 | 1.7% |
| Q3 2025 | Buy | 6,400,708 | 1.8% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.